A case study in generic drug use: should there be risk adjustment in incentive payments for the use of generic medications?
CONCLUSIONS: Payers wishing to promote generic substitution should incorporate the potential for substitution of clinically appropriate generic medications as part of incentives for generic utilization to avoid unintended consequences of using a fixed target rate. A practical methodology for determining an MGR is offered.
PMID: 25351970 [PubMed - in process]
Source: Journal of Managed Care Pharmacy - Category: Drugs & Pharmacology Tags: J Manag Care Pharm Source Type: research
More News: Academia | Chemistry | Diabetes | Diabetes Mellitus | Drugs & Pharmacology | Endocrinology | Health Management | Hypertension | Managed Care | Medicare | Study